Opportunity to Ask Questions. The Investor has had the opportunity to ask questions and receive answers from the Company or any authorized person acting on its behalf concerning the Company and its business and to obtain any additional information, to the extent possessed by the Company (or to the extent it could have been acquired by the Company without unreasonable effort or expense) necessary to verify the accuracy of the information received by the Investor. In connection therewith, the Investor acknowledges that (s)he has had the opportunity to discuss the Company’s business, management and financial affairs with the Company’s management or any authorized person acting on its behalf.
Appears in 16 contracts
Samples: Subscription Agreement (MYnd Analytics, Inc.), Subscription Agreement (MYnd Analytics, Inc.), Subscription Agreement (MYnd Analytics, Inc.)
Opportunity to Ask Questions. The Investor has had the opportunity to ask questions and receive answers from the Company or any authorized person acting on its behalf concerning the Company and its business and to obtain any additional information, to the extent possessed by the Company (or to the extent it could have been acquired by the Company without unreasonable effort or expense) necessary to verify the accuracy of the information received by the Investor. In connection therewith, the Investor acknowledges that (s)he the Investor has had the opportunity to discuss the Company’s business, management and financial affairs with the Company’s management or any authorized person acting on its behalf.
Appears in 4 contracts
Samples: Subscription Agreement (Asterias Biotherapeutics, Inc.), Subscription Agreement (Biotime Inc), Subscription Agreement (Asterias Biotherapeutics, Inc.)
